Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial

被引：0

作者：

Lu, S. ^{[1
]}

Jian, H. ^{[1
]}

Zhang, Y. ^{[2
]}

Song, Z. ^{[2
]}

Zhao, Y. ^{[3
]}

Wang, P. ^{[4
]}

Jiang, L. ^{[1
]}

Gong, Y. ^{[5
]}

Zhou, J. ^{[6
]}

Dong, X. ^{[7
]}

Yang, N. ^{[8
]}

Fang, J. ^{[9
]}

Zhuang, W. ^{[10
]}

Cang, S. ^{[11
]}

Ma, R. ^{[12
]}

Shi, J. ^{[13
]}

Wu, P. ^{[14
]}

Lu, J. ^{[15
]}

Xiang, Z. ^{[16
]}

Shi, Z. ^{[16
]}

Zhang, L. ^{[16
]}

Wang, Y. ^{[16
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Lung Canc Ctr, Shanghai Chest Hosp, Shanghai, Peoples R China

[2] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China

[3] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China

[4] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Peoples R China

[5] Chongqing Univ, Chongqing Canc Hosp, Canc Hosp, Chongqing, Peoples R China

[6] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China

[7] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Changsha, Peoples R China

[8] Hunan Canc Hosp, Changsha, Peoples R China

[9] Beijing Canc Hosp, Beijing, Peoples R China

[10] Fujian Prov Canc Hosp, Fuzhou, Peoples R China

[11] Henan Prov Peoples Hosp, Zhengzhou, Peoples R China

[12] Liaoning Canc Hosp, Shenyang, Peoples R China

[13] Linyi Canc Hosp, Linyi, Peoples R China

[14] Gen Hosp Ningxia Med Univ, Yinchuan, Peoples R China

[15] Nantong Tumor Hosp, Nantong, Peoples R China

[16] InventisBio Co Ltd, Shanghai, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期

关键词：

Non-small cell lung cancer; KRAS G12C mutation; Small molecular inhibitor;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA03.07

引用

页码：S11 / S11

页数：1